Pharmafile Logo

Pegasus Moves to Brighton

April 29, 2014 |  

Top UK Healthcare Communications Consultancy Moves to Brighton

‘Oh we do like to be beside the seaside!’ Pegasus returns to its roots in Brighton  

As it approaches 20 successful years of business, Worthing based firm Pegasus, the fourth biggest independent health communications consultancy in the UK, is moving the company to its seaside neighbour, Brighton.
 

Keen to stay by the sea, the company is making the short journey along the coast to neighbouring Brighton, positioning itself within the heart of the North Laines on Church Road’s ‘Sovereign House’. The move was prompted by a number of factors; the growing number of staff living in Brighton & Hove and the surrounding area; the strength of its digital and creative offering, and the recruitment pull of being by the sea and at the end of the London commuting line.  

The company’s time in Worthing has seen many successes including significant growth, scores of awards and the launch of new integrated services.  In the last six years alone, staff numbers have grown from 20 to a team of 70. Tripling its income, the consultancy has become a top four UK healthcare comms consultancy and was recently ranked 22nd on The Sunday Times ‘100 Best Places to Work’ (2014).
 

Lisa Bradley, Founder & Managing Director of Pegasus says;
“Whilst Worthing has been a good home for us and helped us get to where we are today, Brighton is actually where the company began all those years ago…in Hove actually.  In many ways it feels like we’re coming home! Brighton offers new opportunities that we are keen to uncover, and being the digital hub of the UK will allow us to strengthen our digital division further. We look forward to supporting the business community and hope to integrate ourselves as well as we have in Worthing.”
 

Pegasus has evolved from a traditional PR agency to become an integrated comms consultancy that offers a multiservice approach to its clients, including; social, digital and creative services.  

With campaigns that span local, national and international markets and the creation of a network of global independent affiliate agencies across five continents, it’s no surprise that Pegasus represents a raft of well known companies and brands such as; GSK, Pfizer, Boehringer Ingelheim, Bayer, Thornton & Ross, Holland & Barrett, Sanofi, Bio-Oil and Danone to name a few.    

As of the 28th of April, Pegasus’s new address will be: Sovereign House, North Laines, Church
Street, BN1 1UJ

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

Video: Self-pay and Emerging Markets

A key feature of emerging markets is that patients often have to pay for a high proportion of their healthcare costs themselves. For all but the most severe conditions, public...

News: Therapy Watch HCV expands into 4 additional EU markets

The HCV market has been growing and changing remarkably quickly and with the development of new and improving drugs, the treatment of HCV has moved on in a short space...

News: Research Partnership launches new patient report – Living with Ulcerative Colitis

Living with UC is a quantitative study conducted online amongst 325 patients, including both adult and paediatric patients diagnosed with ulcerative colitis in 5 EU markets (France, Germany, Italy, Spain...

Summer Intern experience at Research Partnership

We look for bright and inquisitive people who want to learn in a company that's pushing the boundaries of pharmaceutical market research

Double win at Communiqué 2016: Pegasus scoops awards for Consultancy of the Year (for the second time!) and Excellence in Media Relations

Pegasus, an Ashfield company, part of UDG Healthcare plc, is delighted to have won the prestigious Consultancy of the Year award at the 2016 Communiqué Awards in London. The judges...

Beyond Andrology: Trends in Men’s Health in Emerging Markets

Published in eyeforpharma July 2016 by Rachel Howard

Pharma & life sciences division growth allows Pegasus to fill three new senior positions

Pegasus has expanded its pharma & life sciences senior team by appointing a new Associate Director and promoting two members of the existing team to Account Directors.

Infographic: HIV Market Snapshot

Our latest HIV infographic, taken from data collected from syndicated tracking study Therapy Watch, reveals that more than 3 in 5 naive or switch patients are currently treated with a STR (single...

Infographic: The vaccine opportunity in Asia

As predicted, the vaccine market in emerging and developing countries has continued to expand. While the global vaccine market is expected to grow at around 12% annually over the next...

Webinar: What next for biosimilars?

Tuesday 19th July 15:00 BST/10:00 EDT/16:00 CEST